caa a22 4500 445311037 CHVBK 20180317142630.0 cr unu---uuuuu 170323e20111101xx s 000 0 eng 10.1007/s00404-010-1750-4 doi (NATIONALLICENCE)springer-10.1007/s00404-010-1750-4 Hepatic resection as part of secondary cytoreductive surgery for recurrent ovarian cancer involving the liver [Elektronische Daten] [Hyun-Jin Roh, Dae-Yeon Kim, Won-Duk Joo, Hang-Jo Yoo, Jong-Hyeuk Kim, Yong-Man Kim, Young-Tak Kim, Joo-Hyun Nam] Purpose: The aims of this study were to assess the surgical outcomes and to also determine the prognostic factors in patients with surgically resectable liver metastases for recurrent ovarian cancer. Methods: Between 1991 and 2008, 18 patients with recurrent ovarian cancer who underwent hepatic resection as part of secondary cytoreductive surgery were identified from the tumor registry pathology database. Parameters for safety, efficacy, and survival data were considered as primary endpoints. Results: Hepatic resections included wedge resection (n=4), unisegmentectomy (n=13), and bisegmentectomy (n=1). There were no surgery-related deaths. Only one patient (5.6%) had postoperative major complications. The median postoperative hospitalization was 15.5days (range 11-46days). The prognostic factors associated with improved survival were less abdominal than pelvic disease (38 vs. 11months, P=0.032), optimal cytoreduction (40 vs. 9months, P=0.0004), and negative margin status of the hepatic resection (40 vs. 9months, P=0.0196). The overall median survival after hepatic resection was 38months (range 3-78months). Conclusion: Hepatic resection for recurrent ovarian cancer is safe and is associated with a favorable outcome. Parenchymal liver metastases should not exclude attempts at optimal secondary cytoreductive surgery, and especially, patients with solitary liver metastases should be considered for hepatic resection. Springer-Verlag, 2010 Hepatic resection nationallicence Recurrent ovarian cancer nationallicence Optimal cytoreduction nationallicence Negative margin status nationallicence Roh Hyun-Jin Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Ulsan College of Medicine, Ulsan University Hospital, Ulsan, Republic of Korea aut Kim Dae-Yeon Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Ulsan College of Medicine, Asan Medical Center, 388-1 Poongnap-2dong, Songpa-Gu, 138-736, Seoul, Republic of Korea aut Joo Won-Duk Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Ulsan College of Medicine, Ulsan University Hospital, Ulsan, Republic of Korea aut Yoo Hang-Jo Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Ulsan College of Medicine, Ulsan University Hospital, Ulsan, Republic of Korea aut Kim Jong-Hyeuk Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Ulsan College of Medicine, Asan Medical Center, 388-1 Poongnap-2dong, Songpa-Gu, 138-736, Seoul, Republic of Korea aut Kim Yong-Man Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Ulsan College of Medicine, Asan Medical Center, 388-1 Poongnap-2dong, Songpa-Gu, 138-736, Seoul, Republic of Korea aut Kim Young-Tak Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Ulsan College of Medicine, Asan Medical Center, 388-1 Poongnap-2dong, Songpa-Gu, 138-736, Seoul, Republic of Korea aut Nam Joo-Hyun Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Ulsan College of Medicine, Asan Medical Center, 388-1 Poongnap-2dong, Songpa-Gu, 138-736, Seoul, Republic of Korea aut Archives of Gynecology and Obstetrics Springer-Verlag 284/5(2011-11-01), 1223-1229 0932-0067 284:5<1223 2011 284 404 https://doi.org/10.1007/s00404-010-1750-4 text/html Onlinezugriff via DOI 1 research-article jats NATIONALLICENCE 856 40 https://doi.org/10.1007/s00404-010-1750-4 text/html Onlinezugriff via DOI NATIONALLICENCE 700 1- Roh Hyun-Jin Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Ulsan College of Medicine, Ulsan University Hospital, Ulsan, Republic of Korea aut NATIONALLICENCE 700 1- Kim Dae-Yeon Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Ulsan College of Medicine, Asan Medical Center, 388-1 Poongnap-2dong, Songpa-Gu, 138-736, Seoul, Republic of Korea aut NATIONALLICENCE 700 1- Joo Won-Duk Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Ulsan College of Medicine, Ulsan University Hospital, Ulsan, Republic of Korea aut NATIONALLICENCE 700 1- Yoo Hang-Jo Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Ulsan College of Medicine, Ulsan University Hospital, Ulsan, Republic of Korea aut NATIONALLICENCE 700 1- Kim Jong-Hyeuk Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Ulsan College of Medicine, Asan Medical Center, 388-1 Poongnap-2dong, Songpa-Gu, 138-736, Seoul, Republic of Korea aut NATIONALLICENCE 700 1- Kim Yong-Man Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Ulsan College of Medicine, Asan Medical Center, 388-1 Poongnap-2dong, Songpa-Gu, 138-736, Seoul, Republic of Korea aut NATIONALLICENCE 700 1- Kim Young-Tak Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Ulsan College of Medicine, Asan Medical Center, 388-1 Poongnap-2dong, Songpa-Gu, 138-736, Seoul, Republic of Korea aut NATIONALLICENCE 700 1- Nam Joo-Hyun Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Ulsan College of Medicine, Asan Medical Center, 388-1 Poongnap-2dong, Songpa-Gu, 138-736, Seoul, Republic of Korea aut NATIONALLICENCE 773 0- Archives of Gynecology and Obstetrics Springer-Verlag 284/5(2011-11-01), 1223-1229 0932-0067 284:5<1223 2011 284 404 Metadata rights reserved Springer special CC-BY-NC licence nationallicence BK010053 XK010053 XK010000 NATIONALLICENCE NATIONALLICENCE NL-springer